{"disease":{"id":"symptomatic-aortic-stenosis","name":"symptomatic aortic stenosis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02664649","title":"Anti-Thrombotic Strategy After Trans-Aortic Valve Implantation for Aortic Stenosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1510,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT04091048","title":"Optimize PRO Study","phase":"","overall_status":"COMPLETED","enrollment_count":1127,"lead_sponsor_name":"Medtronic Cardiovascular","has_results":true},{"nct_id":"NCT03222128","title":"PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - S3 Intermediate","phase":"NA","overall_status":"COMPLETED","enrollment_count":1074,"lead_sponsor_name":"Edwards Lifesciences","has_results":true},{"nct_id":"NCT03752866","title":"CONFIDENCE Registry to Assess Safety and Performance of Portico System to Treat Patients With Severe Aortic Stenosis.","phase":"NA","overall_status":"COMPLETED","enrollment_count":1001,"lead_sponsor_name":"Abbott Medical Devices","has_results":true},{"nct_id":"NCT02184442","title":"The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves - PII B","phase":"NA","overall_status":"COMPLETED","enrollment_count":560,"lead_sponsor_name":"Edwards Lifesciences","has_results":true},{"nct_id":"NCT02424370","title":"Geriatric Evaluation to Predict Mortality and Functional Recovery After Trans Aortic Valve Implantation","phase":"","overall_status":"COMPLETED","enrollment_count":515,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT04694859","title":"Romanian National Registry of Outcomes After Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis - RO-TAVI","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Romanian Society of Cardiology","has_results":false},{"nct_id":"NCT04788888","title":"Evaluation of TAVR Using the NAVITOR Valve in a Global Investigation","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":434,"lead_sponsor_name":"Abbott Medical Devices","has_results":true},{"nct_id":"NCT03865043","title":"Vascular Complications and Bleeding After Transfemoral TAVI","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT02956915","title":"Evaluation of Length of Stay After TF-TAVI","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"University Hospital, Rouen","has_results":false},{"nct_id":"NCT03402724","title":"Long-term Clinical and Echographic Follow-up (More Than 4 Years) After TAVI.","phase":"","overall_status":"COMPLETED","enrollment_count":178,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT05711186","title":"Structured Shared Decision Making for Patients Undergoing SAVR or TAVR","phase":"NA","overall_status":"RECRUITING","enrollment_count":140,"lead_sponsor_name":"Insel Gruppe AG, University Hospital Bern","has_results":false},{"nct_id":"NCT05326126","title":"Microvascular Function in Patients Undergoing Transcatheter Aortic Valve Implant (TAVI) for Severe Symptomatic Aortic Stenosis: Association With Myocardial Fibrosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":75,"lead_sponsor_name":"Matteo Montorfano","has_results":false},{"nct_id":"NCT02797158","title":"Post TAVI Coronary REVASCularisation Guided by Myocardial Perfusion Imaging: a Prospective Open Label Pilot Study: The REVASC-TAVI Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":71,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT03314857","title":"China XT: Safety and Effectiveness of Edwards Lifesciences SAPIEN XT THV in the Chinese Population","phase":"NA","overall_status":"COMPLETED","enrollment_count":67,"lead_sponsor_name":"Edwards Lifesciences","has_results":true},{"nct_id":"NCT03466918","title":"China S3: Safety and Effectiveness of Edwards Lifesciences SAPIEN 3 THV in the Chinese Population","phase":"NA","overall_status":"COMPLETED","enrollment_count":58,"lead_sponsor_name":"Edwards Lifesciences","has_results":true},{"nct_id":"NCT04982588","title":"Evolut PRO China Clinical Study","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":52,"lead_sponsor_name":"Medtronic Cardiovascular","has_results":true},{"nct_id":"NCT03724812","title":"FlexNav EU CE Mark Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":46,"lead_sponsor_name":"Abbott Medical Devices","has_results":true},{"nct_id":"NCT04331145","title":"Platelet REACtivity According to TICagrelor Dose After Transcatheter AorticValve Implantation","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Andres Iñiguez Romo","has_results":false},{"nct_id":"NCT04663334","title":"Change in Coronary Microcirculation and FFR After TAVI in Patients With Cardiovascular Comorbidities","phase":"","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"Nantes University Hospital","has_results":false},{"nct_id":"NCT03247465","title":"Image Fusion and Calcification Raising in Trans Aortic Valve Implantation","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Nantes University Hospital","has_results":false}],"total":21},"guidelines":[],"source":"Drug Landscape verified database"}